Overview

Micardis®. Observational Study in Patients With Essential Hypertension

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to supplement, under conditions of usual clinical practice, the data on the efficacy and safety of Micardis® collected during the clinical studies.
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Telmisartan